Guest: Gates B. Colbert, MD, FASN 


 
 Although immunosuppressive therapy has been the backbone of IgA nephropathy (IgAN) treatment, this type of approach comes with several challenges. Here to share how non-immunosuppressive treatments could help revolutionize the IgAN treatment landscape is Dr. Gates B. Colbert, Assistant Clinical Professor at Texas A&M College of Medicine.

Guest: Gates B. Colbert, MD, FASN Although immunosuppressive therapy has been the backbone of IgA nephropathy (IgAN) treatment, this type of approach comes with several challenges. Here to share how non-immunosuppressive treatments could help revolutionize the IgAN treatment landscape is Dr. Gates B. Colbert, Assistant Clinical Professor at Texas A&M College of Medicine.

Guest: Gates B. Colbert, MD, FASN 


 
 Although immunosuppressive therapy has been the backbone of IgA nephropathy (IgAN) treatment, this type of approach comes with several challenges. Here to share how non-immunosuppressive treatments could help revolutionize the IgAN treatment landscape is Dr. Gates B. Colbert, Assistant Clinical Professor at Texas A&amp;M College of Medicine.

Moving Beyond Immunosuppressive Therapy in IgAN

Tune in to interviews with the top thought leaders in medicine exploring the clinical and professional issues that are foremost in the minds of the medical community. Join us at the Clinician's Roundtable for discussions on a vast range of topics that every medical professional should know about.

Share Moving Beyond Immunosuppressive Therapy in IgAN

Sign up to save your podcasts

Moving Beyond Immunosuppressive Therapy in IgAN

Moving Beyond Immunosuppressive Therapy in IgAN

More shows like Clinician's Roundtable

The Peter Attia Drive

Huberman Lab